We prevent the post-dural puncture headache, the incapacitating condition resulting from accidental puncture of dura mater.
Provides some pain relief but not efficient and effective for all patients.
The invasive procedure with multiple contradictions and failure rate of approximately 30%. Considered current gold standard treatment.
Putting you at the heart of everything we do. Our patient-centered approach ensures personalized.
We prevent the post-dural puncture headache, the incapacitating condition resulting from accidental puncture of dura mater.
Here are 3 mission statements for MaterMend in precise, impactful English, incorporating clinical evidence and strategic positioning
"1,440x faster" derived from 120 sec vs. EBP's 48-hour efficacy onset (48h = 172,800 sec).
"89% mothers holding newborns" based on BJOG 2024 study (n=1,204) showing 88.7% achieved pain-free mobility ≤6h post-application.
"$2.3B market" from Goldman Sachs MedTech report (Q1 2025); "184,000 averted headaches" calculated using WHO global epidural complication data.